These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2908747)

  • 21. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists.
    Delchier JC; Soule JC; Mignon M; Goldfain D; Cortot A; Travers B; Isal JP; Bader JP
    Dig Dis Sci; 1986 Jul; 31(7):693-9. PubMed ID: 2873001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G; Parente F
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [H2-blocker refractory ulcers: what can be done?].
    Dammann HG
    Z Gastroenterol; 1992 Apr; 30(4):268-71. PubMed ID: 1351328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical treatment of peptic ulcer disease.
    Rubin W
    Med Clin North Am; 1991 Jul; 75(4):981-98. PubMed ID: 1677060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of "cimetidine resistant" peptic ulcers by ranitidine hydrochloride: a new histamine H2-receptor antagonist.
    Mohammed R; Mitchell KG; Mackay C
    Curr Med Res Opin; 1981; 7(8):523-5. PubMed ID: 6118237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Omeprazole in the therapy of acid-induced diseases].
    Simon B; Dammann HG; Müller P
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omeprazole in H2 receptor antagonist-resistant reflux esophagitis.
    Marciano-D'Amore DA; Paterson WG; Da Costa LR; Beck IT
    J Clin Gastroenterol; 1990 Dec; 12(6):616-20. PubMed ID: 1979984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irradiation-induced duodenal ulcer disease refractory to ranitidine: healing by omeprazole.
    Koop H; Koop I; Klein M; Stumpf M; Massarrat S; Arnold R
    J Clin Gastroenterol; 1989 Dec; 11(6):631-4. PubMed ID: 2573627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
    Lad R; Armstrong D
    Can J Gastroenterol; 1999 Mar; 13(2):135-42. PubMed ID: 10203432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers.
    Deakin M; Williams JG
    Drugs; 1992 Nov; 44(5):709-19. PubMed ID: 1280563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs.
    Di Mario F; Gottardello L; Germanà B; Dotto P; Grassi SA; Vianello F; Battaglia G; Leandro G; Burra P; Salvagnini M
    Ital J Gastroenterol; 1992; 24(3):122-5. PubMed ID: 1348650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
    Brunner GH; Lamberts R; Creutzfeldt W
    Digestion; 1990; 47 Suppl 1():64-8; discussion 76. PubMed ID: 2093018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of sucralfate-induced ulcer healing and relapse.
    Lam SK
    Am J Med; 1989 Jun; 86(6A):122-6. PubMed ID: 2660554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
    Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in the treatment of digestive diseases.
    Sun HS
    J Int Med Res; 1989; 17 Suppl 1():2A-8A. PubMed ID: 2566540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of the H+/K+-adenosine triphosphatase inhibitor omeprazole in peptic ulcer.
    de Bruijne JW; Snel P; Lamers CB
    Digestion; 1989; 44 Suppl 1():25-30. PubMed ID: 2691308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
    Spencer CM; Faulds D
    Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.